This is leading towards increasing R&D in clinical trials for medical devices and medicines
You arent selling a vitamin, you are selling a permissible treat that happens to solve a problem the user is currently fighting
Additionally, GLP-1 RAs with established CV benefitsspecifically liraglutide, subcutaneous semaglutide, dulaglutide, and efpeglenatideare recommended for patients with T2DM and ASCVD to reduce CV events, regardless of baseline or target HbA1c levels or concurrent glucose-lowering therapy (Class I, LoE A)
At the GLP-1 receptor, Tirzepatide activates pathways associated with glycaemic control, gastric emptying, and appetite-related signalling in preclinical models
Portion control: Pay attention to portion sizes to help manage calorie intake and weight
[DOI] [PMC free article] [PubMed] [Google Scholar] 127.Psilopanagioti A., Nikou S., Logotheti S., Arbi M., Chartoumpekis D.V., Papadaki H